Medical Countermeasures W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four CountriesGlobal Biodefense StaffMarch 19, 2025
Medical Countermeasures Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresGlobal Biodefense StaffMarch 18, 2025
Medical Countermeasures Tecovirimat Shown to Lack Efficacy as Treatment for Clade II MpoxGlobal Biodefense StaffMarch 12, 2025
New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Trial Antimicrobial Resistance April 28, 2014 …
Rutgers Awarded $26M to Lead Development of New Antibiotics Antimicrobial Resistance April 28, 2014 …
Novel Agent for Tamiflu-Resistant pH1N1 Influenza Virus Discovered Medical Countermeasures April 24, 2014 …
Researchers Discover Possible New Target to Attack Flu Virus Medical Countermeasures April 13, 2014 …
Notable Contracts: DTRA Small Molecule Countermeasures Research Medical Countermeasures April 10, 2014 …
Rapid, Broad Countermeasures Sought Against Mystery Infections Medical Countermeasures April 8, 2014 …
Pharmocogenomics Has Not Fulfilled Its Promise to Developing Countries Medical Countermeasures April 4, 2014 …
UGA Awarded Grand Challenges Funding for Rotavirus Vaccine Research Medical Countermeasures April 1, 2014 …
USAMRIID Seeks Animal Vaccination Services for Immunogenicity Studies Contracts + Grants March 31, 2014 …
Bacterial Reporters Pave the Way to Living Diagnostics and Therapeutics Medical Countermeasures March 28, 2014 …
